말레이시아 - 영어 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

quantarad technologies sdn bhd - tetrakis (2-methoxyisobutyl isonitrile) copper (i) tetrafluoroborate -

싱가포르 - 영어 - HSA (Health Sciences Authority)

qt instruments (s) pte ltd - tetrakis (2-methoxyisobutyl isonitrile) copper (i) tetrafluoroborate - injection, powder, for solution - 1.0 mg - tetrakis (2-methoxyisobutyl isonitrile) copper (i) tetrafluoroborate 1.0 mg

싱가포르 - 영어 - HSA (Health Sciences Authority)

qt instruments (s) pte ltd - tetrakis (2-methoxy-isobutyl-isonitrile) copper (1) tetrafluoroborate - injection, powder, lyophilized, for solution - 1.0 mg/vial - tetrakis (2-methoxy-isobutyl-isonitrile) copper (1) tetrafluoroborate 1.0 mg/vial

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

draximage (uk) limited - tetrakis (2-methoxy isobutyl isonitrile) copper (i) tetrafluorolborate - kit for radiopharmaceutical preparation - 1 milligram

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

global medical solutions australia pty limited t/a radpharm scientific - tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate, quantity: 1 mg - injection, powder for - excipient ingredients: cysteine hydrochloride; stannous chloride dihydrate; sodium citrate dihydrate; mannitol - technetium (99mtc) sestamibi is indicated for use in conjunction with stress testing as an adjunct in the diagnosis of ischaemic heart disease. in these patients additional information about ventricular function may be derived by using the first pass technique. indications as at 23 november 1999: technetium [99mtc] sestamibi is indicated for use in conjunction with stress testing as an adjunct in the diagnosis of ischaemic heart disease. in these patients additional information about ventricular function may be derived by using the first pass technique. technetium [99mtc] sestamibi is indicated as a second line diagnostic aid to assist in the evaluation of patients for whom mammography is inconclusive.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

lantheus mi australia pty ltd - tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate -

몰타 - 영어 - Malta Medicines Authority

pharma-cos limited - cysteine hydrochloride 1 mg, tetrakis (2-methoxy isobutyl isonitrile) copper (i) tetrafluorolborate 1 mg, stannous chloride dihydrate 0.075 mg - powder for solution for injection

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

mallinckrodt australia pty ltd - tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate; tetrakis (2-methoxyisobutylisonitrile) copper (i) tetrafluoroborate; tetrakis (2-methoxyisobutyl isonitrile) copper (i) tetrafluoroborate -

미국 - 영어 - NLM (National Library of Medicine)

lantheus medical imaging, inc. - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate (unii: n6ou7hj70p) (tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate - unii:n6ou7hj70p) - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate 1 mg in 1 ml - myocardial imaging: technetium tc99m sestamibi is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. technetium tc99m sestamibi evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques (e.g., exercise or pharmacologic stress in accordance with the pharmacologic stress agent's labeling). it is usually not possible to determine the age of a myocardial infarction or to differentiate a recent myocardial infarction from ischemia. breast imaging: technetium tc99m sestamibi is indicated for planar imaging as a second line diagnostic drug after mammography to assist in the evaluation of breast lesions in patients with an abnormal mammogram or a palpable breast mass. technetium tc99m sestamibi is not indicated for breast cancer screening, to co

미국 - 영어 - NLM (National Library of Medicine)

lantheus medical imaging, inc. - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate (unii: n6ou7hj70p) (tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate - unii:n6ou7hj70p) - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate 1 mg in 1 ml - myocardial imaging: cardiolite® , kit for the preparation of technetium tc99m sestamibi for injection, is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. cardiolite® evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques (e.g., exercise or pharmacologic stress in accordance with the pharmacologic stress agent's labeling). it is usually not possible to determine the age of a myocardial infarction or to differentiate a recent myocardial infarction from ischemia. breast imaging: miraluma® , kit for the preparation of technetium tc99m sestamibi for injection, is indicated for planar imaging as a second line diagnostic drug after mammography to assist in the evaluation of breast lesions in patients with an abnormal mammogram or a palpa